Lab gadfly PETA pressures AACR, gets retraction from sanctioned scientist

People for the Ethical Treatment of Animals (PETA) may not be on most scientists’ list of Facebook friends, but we’re grateful to them for a hat tip. Several days ago, we were approached by Justin Goodman, associate director of PETA’s laboratory investigations department, with a new twist on an old story.

First, a little history: In September 2009, the Office of Research Integrity sanctioned an ex-Vanderbilt cancer researcher named Nagendra S. Ningaraj. According to the agency, Ningaraj Continue reading Lab gadfly PETA pressures AACR, gets retraction from sanctioned scientist

EurekAlert retracts press release, and a Guardian reporter sanctioned by EurekAlert reports on it

Cross-posted from Embargo Watch

EurekAlert has withdrawn a press release after realizing that it contained unsupported statements about climate change. As Suzanne Goldenberg of The Guardian reports:

An online news service sponsored by the world’s premier scientific association unwittingly promoted a study making the false claim that catastrophic global warming would occur within nine years, the Guardian has learned.

The study, by an NGO based in Argentina, claimed the planet would warm by 2.4C by 2020 and projected dire consequences for global food supply. A press release for the Food Gap study was carried by EurekAlert!, the news service operated by the American Association for the Advancement of Science (AAAS) , and the story was picked up by a number of international news organisations on Tuesday.

Read the rest of Goldenberg’s story. It’s quite illuminating.

EurekAlert posted a statement that reads, in part: Continue reading EurekAlert retracts press release, and a Guardian reporter sanctioned by EurekAlert reports on it

A lightning-fast JNCI retraction shows how science should work

The retraction last week of a commentary in the Journal of the National Cancer Institute (JNCI) looks like a nice — and very quick — example of self-correction in science.

The commentary, “Designing a randomized clinical trial to evaluate personalized medicine: a new approach based on risk prediction,” was co-authored by Stuart Baker and Daniel Sargent, and published in the December 1, 2010 issue. The journal published the retraction, and a letter that contained the re-analysis that led to it, on January 12.

The retraction notice: Continue reading A lightning-fast JNCI retraction shows how science should work

Salon retracts 2005 Robert F. Kennedy Jr. piece on alleged autism-vaccine link

Salon today retracted a controversial 2005 story by Robert F. Kennedy, Jr. about an alleged link between autism and thimerosal, the mercury-based preservative formerly used in vaccines.

As Salon explains in their retraction notice, the online magazine had co-published the piece with Rolling Stone. The notice reads, in part: Continue reading Salon retracts 2005 Robert F. Kennedy Jr. piece on alleged autism-vaccine link

Update on Anil Potti: A patient in a trial based on retracted research speaks out; Baggerly on how to prevent the next fiasco

courtesy Duke

A quick post this Sunday morning to draw your attention to two must-read items for anyone interested in the Anil Potti case or in how one goes about checking data. (A second paper by Potti et al was officially retracted on Friday.)

First, a terrific profile of Joyce Shoffner in the Charlotte News & Observer. Shoffner

was one of 110 Duke patients enrolled in three clinical trials based on the research of Dr. Anil Potti, who resigned in November as an associate professor at Duke.

Here at Retraction Watch, we obviously think all retractions are worth following. But we hope this story will convince those who shrug and say such items are inside baseball, or “none of your damn business,” that they need to re-evaluate their positions. This is where the rubber hits the road: Continue reading Update on Anil Potti: A patient in a trial based on retracted research speaks out; Baggerly on how to prevent the next fiasco

Nature Medicine makes it official, retracting Anil Potti paper

 

courtesy Nature

Nature Medicine has retracted a paper that Anil Potti’s co-author, Joseph Nevins, requested be withdrawn in November.

This is the second retraction of a paper by Potti, who resigned from his post at Duke in November in the midst of an investigation into scientific misconduct. The first retraction was in the Journal of Clinical Oncology.

According to the Nature Medicine retraction notice: Continue reading Nature Medicine makes it official, retracting Anil Potti paper

Authors of Journal of Immunology paper retract it after realizing they had ordered the wrong mice

The authors of a 2006 Journal of Immunology study have retracted it after it dawned on them that they used the wrong mice.

The study, “Endogenous IL-1R1 Signaling Is Critical for Cognate CD41 T Cell Help for Induction of In Vivo Type 1 and Type 2 Antipolysaccharide and Antiprotein Ig Isotype Responses to Intact Streptococcus pneumoniae, but Not to a Soluble Pneumococcal Conjugate Vaccine,” has been cited 11 times, according to Thomson Scientific’s Web of Knowledge.

According to the retraction notice: Continue reading Authors of Journal of Immunology paper retract it after realizing they had ordered the wrong mice

Why was that paper retracted? Editor to Retraction Watch: “It’s none of your damn business”

L. Henry Edmunds, photo by University of Pennsylvania

Yesterday, we reported on the retraction of a 2004 study in the Annals of Thoracic Surgery. As we noted, the notice’s language was, um, fuzzy, referring vaguely to

an investigation by the University of Florida, which uncovered instances of repetitious, tabulated data from previously published studies.

Today, we are slightly more clear, although what we really got was an earful of other language.

We had the pleasure of speaking this morning with L. Henry Edmunds, Jr., the long-time editor of the Annals of Thoracic Surgery, who gave us a better sense of why his retraction notice was so delicately worded. Edmunds, responding to question of why the letter didn’t say more about the matter:

It’s none of your damn business.

Ranting against “journalists and bloggists,” Edmunds, a cardiac surgeon at the University of Pennsylvania, said the purpose of the retraction notice was merely Continue reading Why was that paper retracted? Editor to Retraction Watch: “It’s none of your damn business”

Thoracic surgery journal retracts hypertension study marred by troubled data

The Annals of Thoracic Surgery has retracted a 2004 article by a group of Florida researchers who were found by their university to have misrepresented the provenance of their data.

If that construction sounds a trifle precious (er, weasel-y), that’s because the retraction notice does, too: Continue reading Thoracic surgery journal retracts hypertension study marred by troubled data

Update on Small retraction: Co-author says failed follow-up led to detection of tech’s fraud

We have a little more information on the lab-tech case out of the University of Chicago that we reported on last week. A brief summary: The journal Small retracted a 2007 paper on a method of producing insulin-secreting cells after one of the co-authors, a technician named Matthew Connors, was found to have fabricated a key figure. Connors has had a long career as a lab tech and his name has appeared on several published articles.

Reached by e-mail, Milan Mrksich, a chemistry professor at Chicago and a co-author of the retracted paper– as well as an investigator for the Howard Hughes Medical Institute — told us that the fraud surfaced during follow-up research: Continue reading Update on Small retraction: Co-author says failed follow-up led to detection of tech’s fraud